January 30, 2025 · Form 4 insider transaction
Wellington Biomedical Innovation Master Investors (Cayman) II L.P. bought 1,857,699 shares of MTSR, a transaction worth N/A. The trade was recorded as conversion of a derivative and disclosed on an SEC Form 4, filed 4 days after the transaction.
Each share of Series B Preferred Stock automatically converted into Common Stock on a 2.349723-for-1 basis upon closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock had no expiration date.